Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2)

被引:47
|
作者
Janke, Kirsten [1 ]
Brockmeier, Ulf [1 ]
Kuhlmann, Katja [2 ]
Eisenacher, Martin [2 ]
Nolde, Jan [3 ]
Meyer, Helmut E. [2 ]
Mairbaeurl, Heimo [4 ]
Metzen, Eric [1 ]
机构
[1] Univ Duisburg Essen, Fac Med, Inst Physiol, D-45147 Essen, Germany
[2] Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany
[3] Med Univ Lubeck, Dept Surg, D-23538 Lubeck, Germany
[4] Univ Heidelberg Hosp, Dept Internal Med Sports Med, D-69120 Heidelberg, Germany
关键词
Cell polarity; Hydroxylation; Hypoxia; Protein interaction; ANKYRIN REPEAT DOMAIN; BLOOD-BRAIN-BARRIER; ASPARAGINYL HYDROXYLASE; BETA-HYDROXYLATION; HYPOXIA; ALPHA; NOTCH; PERMEABILITY; HIF-1-ALPHA; STABILITY;
D O I
10.1242/jcs.117564
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The asparaginyl hydroxylase factor inhibiting HIF-1 (FIH-1) is an important suppressor of hypoxia-inducible factor (HIF) activity. In addition to HIF-alpha, FIH-1 was previously shown to hydroxylate other substrates within a highly conserved protein interaction domain, termed the ankyrin repeat domain (ARD). However, to date, the biological role of FIH-1-dependent ARD hydroxylation could not be clarified for any ARD-containing substrate. The apoptosis-stimulating p53-binding protein (ASPP) family members were initially identified as highly conserved regulators of the tumour suppressor p53. In addition, ASPP2 was shown to be important for the regulation of cell polarity through interaction with partitioning defective 3 homolog (Par-3). Using mass spectrometry we identified ASPP2 as a new substrate of FIH-1 but inhibitory ASPP (iASPP) was not hydroxylated. We demonstrated that ASPP2 asparagine 986 (N986) is a single hydroxylation site located within the ARD. ASPP2 protein levels and stability were not affected by depletion or inhibition of FIH-1. However, FIH-1 depletion did lead to impaired binding of Par-3 to ASPP2 while the interaction between ASPP2 and p53, apoptosis and proliferation of the cancer cells were not affected. Depletion of FIH-1 and incubation with the hydroxylase inhibitor dimethyloxalylglycine (DMOG) resulted in relocation of ASPP2 from cell-cell contacts to the cytosol. Our data thus demonstrate that protein interactions of ARD-containing substrates can be modified by FIH-1-dependent hydroxylation. The large cellular pool of ARD-containing proteins suggests that FIH-1 can affect a broad range of cellular functions and signalling pathways under certain conditions, for example, in response to severe hypoxia.
引用
收藏
页码:2629 / 2640
页数:12
相关论文
共 50 条
  • [41] Apoptosis-stimulating protein of p53 (ASPP) participates in the regulation of apoptosis in Litopenaeus vannamei under ammonia-N and nitrite-N stress
    Zhou, Xiaoxun
    Zhuo, Hongbiao
    Lin, Lanting
    Zhang, Yuan
    Li, Jinyan
    Fu, Shuo
    Wu, Guangbo
    Guo, Chaoan
    Liu, Jianyong
    AQUACULTURE REPORTS, 2024, 39
  • [42] Inhibitory member of the apoptosis-stimulating protein of p53 (ASPP) family promotes growth and tumorigenesis in human p53-deficient prostate cancer cells
    Zhang, B.
    Xiao, H. J.
    Chen, J.
    Tao, X.
    Cai, L. H.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2011, 14 (03) : 219 - 224
  • [43] Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: Correlation with clinical outcome
    Lossos, IS
    Natkunam, Y
    Levy, R
    Lopez, CD
    LEUKEMIA & LYMPHOMA, 2002, 43 (12) : 2309 - 2317
  • [44] ONCOGENIC ASPP2KAPPA(K), A DOMINANT-NEGATIVE ISOFORM OF THE APOPTOSIS STIMULATING PROTEIN OF P53-2 (ASPP2) PROMOTES CLASSICAL HALLMARKS OF CANCER IN GLIOBLASTOMA
    Hafner, M.
    Ruiba, A.
    Kampa, L.
    Sommer, I.
    Ahrens, A.
    Kalin, V.
    Zeitlberger, A.
    Buchauer, K.
    Plasswilm, L.
    Hundsberger, T.
    Neidert, M.
    Schittenhelm, M. M.
    Kampa-Schittenhelm, K. M.
    NEURO-ONCOLOGY, 2023, 25
  • [45] Inhibitor of apoptosis-stimulating p53 protein protects against inflammatory bowel disease in mice models by inhibiting the nuclear factor kappa B signaling
    Qian, Ke
    Yuan, Lianwen
    Wang, Shalong
    Kuang, Yong
    Jin, Qianqian
    Long, Dongju
    Jiang, Yuhong
    Zhao, Hua
    Liu, Kuijie
    Yao, Hongliang
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2021, 205 (02): : 246 - 256
  • [46] Proteins that interact with Apoptotic Stimulator Protein of p53, ASPP2, in the yeast two-hybrid system
    Bray, BA
    Grigoreff, Y
    Forbus, JD
    Beavers, SY
    Ruiz, MI
    Butler, KA
    Warthen, LM
    Rohde, LH
    FASEB JOURNAL, 2004, 18 (08): : C105 - C106
  • [47] Direct interactions between HIF-1α and Mdm2 modulate p53 function
    Chen, DL
    Li, MY
    Luo, JY
    Gu, W
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (16) : 13595 - 13598
  • [48] Role of Kruppel-like factor 4 in regulating inhibitor of apoptosis-stimulating protein of p53 in the progression of gastric cancer
    Wang, Lulu
    Li, Yan
    Li, Luchun
    Wu, Zhijuan
    Wu, Yongzhong
    Ma, Huiwen
    Yu, Huiqing
    Yang, Dan
    Wang, Donglin
    ONCOLOGY LETTERS, 2018, 15 (05) : 6865 - 6872
  • [49] ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells
    Wang, Y.
    Godin-Heymann, N.
    Wang, X. Dan
    Bergamaschi, D.
    Llanos, S.
    Lu, X.
    CELL DEATH AND DIFFERENTIATION, 2013, 20 (04): : 525 - 534
  • [50] Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study
    Xie, Xiao-Feng
    Yang, Qing
    Chi, Jun
    Yang, Xian-Zi
    Wang, Hui-Yun
    Xu, Guo-Liang
    CHINESE JOURNAL OF CANCER, 2017, 36